Recursion Pharmaceuticals (RXRX) Up 6.5% Since Last Earnings Report: Can It Continue?

It has been about a month since the last earnings report for Recursion Pharmaceuticals (RXRX) . Shares have added about 6.5% in that time frame, outperforming the S&P 500.But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Recursion Pharmaceuticals due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the im ...